These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation. Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270 [TBL] [Abstract][Full Text] [Related]
8. Assessing pharmacokinetic and pharmacodynamic interactions in clinical trials of antiepileptic drugs. Reife RA Adv Neurol; 1998; 76():95-103. PubMed ID: 9408466 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM). Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252 [TBL] [Abstract][Full Text] [Related]
10. Early drug distribution: a generally neglected aspect of pharmacokinetics of particular relevance to intravenously administered anesthetic agents. Henthorn TK; Krejcie TC; Avram MJ Clin Pharmacol Ther; 2008 Jul; 84(1):18-22. PubMed ID: 18563069 [TBL] [Abstract][Full Text] [Related]
11. Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia. Haas DA; Harper DG Anesth Prog; 1992; 39(3):61-8. PubMed ID: 1308374 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic modeling in acute and chronic pain: an overview of the recent literature. Martini C; Olofsen E; Yassen A; Aarts L; Dahan A Expert Rev Clin Pharmacol; 2011 Nov; 4(6):719-28. PubMed ID: 22111858 [TBL] [Abstract][Full Text] [Related]
14. Impact of perioperative lidocaine infusion and bis monitorization on remifentanil dosage in hypotensive anesthesia. Uzun S; Yuce Y; Erden A; Aypar U Eur Rev Med Pharmacol Sci; 2014; 18(4):559-65. PubMed ID: 24610623 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological models and their use in clinical anaesthesia. Schwilden H; Stoeckel H; Schüttler J; Lauven PM Eur J Anaesthesiol; 1986 May; 3(3):175-208. PubMed ID: 3536492 [TBL] [Abstract][Full Text] [Related]
16. Models for assessing the relationship between drug concentration and drug effect in performance horses. Kamerling SG; Owens JG Br Vet J; 1994; 150(6):507-25. PubMed ID: 7850442 [TBL] [Abstract][Full Text] [Related]
17. Response surface models in the field of anesthesia: A crash course. Liou JY; Tsou MY; Ting CK Acta Anaesthesiol Taiwan; 2015 Dec; 53(4):139-45. PubMed ID: 26321504 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics and pharmacodynamics in anesthesia, intensive care and pain medicine. Heeremans EH; Proost JH; Eleveld DJ; Absalom AR; Struys MM Curr Opin Anaesthesiol; 2010 Aug; 23(4):479-84. PubMed ID: 20610985 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic modeling in drug research and development. Derendorf H; Lesko LJ; Chaikin P; Colburn WA; Lee P; Miller R; Powell R; Rhodes G; Stanski D; Venitz J J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1399-418. PubMed ID: 11185661 [TBL] [Abstract][Full Text] [Related]
20. Local anesthetic systemic toxicity: Continuing Professional Development. El-Boghdadly K; Chin KJ Can J Anaesth; 2016 Mar; 63(3):330-49. PubMed ID: 26830640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]